Nurix Therapeutics, Inc. (NASDAQ:NRIX), a biopharmaceutical company specializing in protein degradation therapies, has been ...
Y-mAbs Therapeutics, Inc. (NASDAQ:YMAB), a commercial-stage biopharmaceutical company with a "GOOD" InvestingPro Financial ...
Two top clinicians have been disciplined amid growing concern that Kaiser’s system for monitoring research safety and ethics ...
Cathie Wood is piling into little-known AI stock Tempus AI, Inc. (NASDAQ:TEM), amassing about 600,000 shares across multiple ...
Thanks to advances in treatment options, a COVID-19 diagnosis is no longer as scary as it once was, at least for most people. A new study, however, suggests that it may now be easier to predict who is ...
Clinical trial agreements (CTAs) form the foundation of any clinical research initiative, establishing the legal and ...
This year, a Chicago-area community information exchange (CIE) is set to launch with the goal of coordinating care for ...
Pathologists supported by a new artificial intelligence tool outperformed Standard of Care/Gold standard in determining ...
Cedars-Sinai names first chief data and AI officer to drive healthcare innovation. In an interview, Mouneer Odeh discusses his goals and challenges in the role.
The Food & Drug Administration (FDA), has quietly taken down their guidance detailing diversity action plans for clinical ...
The FDA has accepted a priority review sNDA for Welireg in adults and pediatric patients with advanced or metastatic ...
A new study, led by USC Mark and Mary Stevens Neuroimaging and Informatics Institute (Stevens INI), will explore structural alterations in the brains of people with bipolar disorder (BD), a chronic ...